About Daewon pharm
Daewon pharm is a publicly listed company based in Seoul (South Korea) founded in 1958. Manufacturer of pharmaceuticals and related healthcare products. The company has 1,330 employees. Its website daewonpharm.com draws about 95 thousand monthly visits. Daewon pharm offers products and services including Potagel Suspension and Health and Wellness Products. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Daewon Pharmaceutical Co., Ltd.
Company details
Daewon Pharm was established in 1958 in Seoul, South Korea, within the pharmaceutical sector. Therapeutic drugs are developed and produced for cardiovascular, respiratory, and neurological areas, alongside related healthcare products. Research and development efforts are directed toward novel formulations and improvements. Operations encompass manufacturing, marketing, and distribution to support patient care globally.
- Headquarters Seoul, South Korea
- Employees 1,330
- Stage Public
- SectorsHealthcare
- Website daewonpharm.com/main/index.jsp
- Social X Facebook Instagram YouTube
- Legal Name Daewon Pharmaceutical Co., Ltd
- Annual Revenue$419.21 M (USD)1.22as on Dec 31, 2025
- Net Profit-$955.54 K (USD)-109.71as on Dec 31, 2025
- EBITDA$18.85 M (USD)-41.39as on Dec 31, 2025
- Employee Count1,330
Products & Services of Daewon pharm
Daewon pharm offers a comprehensive portfolio of products and services, including Potagel Suspension and Health and Wellness Products.
The suspension is manufactured for gastrointestinal treatments and is recognized for its market performance.
Various health products are distributed to support consumer needs in the pharmaceutical sector.
Apps and channels of Daewon pharm
its YouTube channel 대원제약 has 966 subscribers and 30 videos.
Videos from Daewon pharm
The most watched videos on Daewon pharm's YouTube channel, 대원제약 (966 subscribers). Click a video to play it here.
More on 대원제약.
IPO & Listings of Daewon pharm
Daewon pharm is a publicly listed company on the KRX with ticker symbol 003220 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Dec 1999
- Listed onKRX: 003220
- Listed entityDaewon Pharmaceutical Co., Ltd
- Exchange sectorHealth technology
- ISINKR7003220001
- Share price7,880.00 KRW (+0.25% on the day) · 2026-10-14
- Market capitalisation171,373,165,169.00 KRW
- Price to earnings67.3
- EPS (diluted, trailing year)117.16 KRW
- Dividend yield3.18%
- Volume (last session)25,668
Financials of Daewon pharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 605.43B KRW | -1.38B KRW | 27.23B KRW |
| 2024 | 598.16B KRW | 14.21B KRW | 46.45B KRW |
| 2023 | 526.95B KRW | 23.92B KRW | 49.79B KRW |
| 2022 | 478.88B KRW | 31.94B KRW | 62.27B KRW |
| 2021 | 354.18B KRW | 6.99B KRW | 37.11B KRW |
Detailed financial statements for Daewon pharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Daewon pharm
The website of Daewon pharm (daewonpharm.com) receives about 95.4K visits a month.
- Monthly visits95.4K
▲ 11.2% vs previous month
Websites whose visitors overlap most with Daewon pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chabio.com | 100% | 31.6K | #767,207 | View details | |
dapharm.com | dapharm.com | 88% | #620,157 | β | |
| bukwang.co.kr | 88% | 142.7K | #395,152 | View details | |
| kdpharma.co.kr | 88% | 11.5K | #1,661,256 | View details | |
| health.kr | 77% | #14,868 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 30 similar websites and full traffic analytics for Daewon pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Daewon Pharm
Complete news archive for Daewon pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daewon pharm
Daewon pharm was founded in 1958.
Daewon pharm is headquartered in Seoul, South Korea.
Daewon pharm has 1,330 employees.
Annual revenue of Daewon pharm is $419.21M as on Dec 31, 2025.
Daewon Pharm was established in 1958 in Seoul, South Korea, within the pharmaceutical sector. Therapeutic drugs are developed and produced for cardiovascular, respiratory, and neurological areas, alongside related healthcare products. Research and development efforts are directed toward novel formulations and improvements. Operations encompass manufacturing, marketing, and distribution to support patient care globally.
Daewon pharm offers Potagel Suspension and Health and Wellness Products.
Yes, Daewon pharm is publicly traded on KRX under the ticker symbol 003220.
Daewon pharm operates through Daewon Pharmaceutical Co., Ltd.